Bivatuzumab (Anti-CD44v6)
Bivatuzumab (Anti-CD44v6) is a humanized monoclonal antibody targeting against CD44v6 that could acts as a sarcoma target for CAR-redirected CIK cells. MW:145.5 KD.
| Trivial name | BIWA 4; Anti-CD44 Recombinant Antibody |
| Catalog Number | A2555 |
| CAS# | 214559-60-1 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/bivatuzumab-anti-cd44v6.html |